Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The local microenvironment matters in preclinical basic and translational studies of cancer immunology and immunotherapy
William W. Ho, Mikaël J. Pittet, Dai Fukumura, et al.
Cancer Cell (2022) Vol. 40, Iss. 7, pp. 701-702
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Roles of macrophages in tumor development: a spatiotemporal perspective
Mathilde Bied, William W. Ho, Florent Ginhoux, et al.
Cellular and Molecular Immunology (2023) Vol. 20, Iss. 9, pp. 983-992
Open Access | Times Cited: 132
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
Minae An, Arnav Mehta, Byung‐Hoon Min, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 766-785
Open Access | Times Cited: 19
Preclinical models for drug discovery for metastatic disease
Lalage M. Wakefield, Seema Agarwal, Kandice Tanner
Cell (2023) Vol. 186, Iss. 8, pp. 1792-1813
Closed Access | Times Cited: 31
Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors
Lucía López, Luciano Gastón Morosi, Federica La Terza, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Tumor-intrinsic SIRPA promotes sensitivity to checkpoint inhibition immunotherapy in melanoma
Zhicheng Zhou, Mei-Ju May Chen, Yikai Luo, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1324-1340.e8
Open Access | Times Cited: 29
Role of circular RNAs in disease progression and diagnosis of cancers: An overview of recent advanced insights
Safir Ullah Khan, Munir Ullah Khan, Muhammad Imran Khan, et al.
International Journal of Biological Macromolecules (2022) Vol. 220, pp. 973-984
Closed Access | Times Cited: 26
Once upon a prime: DCs shape cancer immunity
Maria Zagorulya, Stefani Spranger
Trends in cancer (2022) Vol. 9, Iss. 2, pp. 172-184
Closed Access | Times Cited: 25
Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma
Jun Ren, Zohreh Amoozgar, Taylor P. Uccello, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 4
Open Access
Understanding the Dual Role of Macrophages in Tumor Growth and Therapy: A Mechanistic Review
Muhammad Summer, Saima Riaz, Shaukat Ali, et al.
Chemistry & Biodiversity (2025)
Closed Access
A Sophisticated Ratiometric Nuclear Medicine Imaging Strategy for Biological Microenvironment Abnormal Factor Detection
Jianxian Ge, H. Jerry Qi, Lishu Zhao, et al.
Advanced Healthcare Materials (2025)
Closed Access
A new promising anticancer agent: A glycosaminoglycan-mimetic derived from the marine bacterial infernan exopolysaccharide
Dominique Heymann, Javier Muñoz-García, Antoine Babuty, et al.
International Journal of Biological Macromolecules (2025) Vol. 308, pp. 142074-142074
Closed Access
Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy
Laura Rodríguez, Roberto M. Amadio, Giulia Maria Piperno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010547-e010547
Open Access
CD47-mediated immune evasion in early-stage lung cancer progression
Cheng‐Hao Chuang, Yen‐Yi Zhen, Juei-Yang Ma, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 720, pp. 150066-150066
Closed Access | Times Cited: 3
Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization
Mohammad R. Nikmaneshi, Rakesh K. Jain, Lance L. Munn
PLoS Computational Biology (2023) Vol. 19, Iss. 6, pp. e1011131-e1011131
Open Access | Times Cited: 8
In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma
Robin G. Rajan, Virneliz Fernández-Vega, Jantzen Sperry, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3289-3289
Open Access | Times Cited: 7
GITR and TIGIT immunotherapy provokes divergent multicellular responses in the tumor microenvironment of gastrointestinal cancers
Anuja Sathe, Carlos Ayala, Xiangqi Bai, et al.
Genome Medicine (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of Sorafenib
Dan G. Duda, Rakesh K. Jain
Cancer Research (2022) Vol. 82, Iss. 20, pp. 3665-3667
Open Access | Times Cited: 9
Citrullinated fibrinogen-SAAs complex causes vascular metastagenesis
Yibing Han, Takeshi Tomita, Masayoshi Kato, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Combined blockade of VEGF, Angiopoietin-2, and PD1 reprograms glioblastoma endothelial cells into quasi-antigen-presenting cells
Zohreh Amoozgar, Jun Ren, Nancy Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6
GITR and TIGIT immunotherapy provokes divergent multi-cellular responses in the tumor microenvironment of gastrointestinal cancers
Anuja Sathe, Carlos Ayala, Xiangqi Bai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 3
Sequential pembrolizumab cooperates with platinum/5FU to remodel the tumor microenvironment in advanced gastric cancer: a phase II chemoimmunotherapy trial
Minae An, Arnav Mehta, Byung‐Hoon Min, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Wnt inhibition alleviates resistance to immune checkpoint blockade in glioblastoma
Rakesh K. Jain, Shanmugarajan Krishnan, Somin Lee, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
5-Oxo-ETE/OXER1: A Link between Tumor Cells and Macrophages Leading to Regulation of Migration
Konstantina Kalyvianaki, Evangelia Maria Salampasi, Elias N. Katsoulieris, et al.
Molecules (2023) Vol. 29, Iss. 1, pp. 224-224
Open Access | Times Cited: 2
DCs targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors
Lucía López‐Rodríguez, Luciano Gastón Morosi, Federica La Terza, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
El sistema inmune y su interminable batalla contra las células tumorales: reconocimiento, eliminación y evasión de la respuesta inmune
Marcela Sofia Güitrón Aviña, Pablo César Ortiz-Lazareno, Fabiola Solorzano‐Ibarra
Revista Bio Ciencias (2024)
Open Access
Page 1 - Next Page

Scroll to top